Name: Garvit Chitkara
Qualification: MBBS, HBNI, DNB
Designation: Surgical Oncologist
Experience: 14 years
Services: Breast Cancer Treatment/ Surgery, Axillary Surgery
Dr. Garvit Chitkara is a highly accomplished surgical oncologist in Mumbai, currently practicing at Nanavati Hospital in Vile Parle. Having been a cancer surgeon for over 15 years, Dr. Chitkara has accumulated specialized knowledge and proficient skills in the field of Breast surgical oncology and oncoplasty.
Dr. Chitkara's goal is to offer all his patients complete breast care in a secure, comforting, and pleasant environment. His thirst for knowledge and commitment to enhancing the quality of his patients' lives drives him to be updated about the most advanced techniques of breast Oncoplastic surgery and delve deep into subjects like Genetics, Molecular Epidemiology, and Clinical research, among others.
In addition to his passion for cancer care and treatment, he is a loving husband, a devoted father to his 2 young boys, a voracious reader, and a movie buff.
Education and Fellowships:
- MBBS, DNB ( Gen Surg)
- HBNI Fellowship in Breast Oncology (TMH)
- Clinical Observership in Breast Oncoplastic in Memorial Sloan Kettering Cancer Centre
Expertise:
- Breast oncoplastic surgery
- Genetics
- Molecular Epidemiology
- Clinical research
Previous Experience:
- 2021 : Associate Professor Surgical Oncology at Tata Memorial Hospital Mumbai till 2021
- 2017: HBNI fellow Breast Oncology at Tata Memorial Hospital till 2017
- 2015: Senior Resident at Tata Memorial Hospital till 2015
- 2013: Senior Resident at Delhi State Cancer Institute till 2013
Awards & Honors :
- Travel Fellowship to 12th European Breast Cancer Conference
- Certificate of Achievement: Harvard Medical School for HMX fundamentals-Genetics
- Certificate of Achievement: Harvard Medical School for HMX Pro: Cancer genomics and Precision oncology
- Member Mumbai Surgical Society
- Certificate Of Achievement: Harvard Medical School for HMX Pro: Genetic Testing and Sequencing
Technologies. - Member European Society of Surgical Oncology
- Member of EUBREAST e.V. Germany
- Member Association of Surgeons of India
Research and Publications
- Organ preservation in splenic abscess-a case report Case report Med J Armed Forces India. 2014 Apr;70(2):195-7
- Corrosive Tracheoesophageal fistula following button battery ingestion Case report Indian Pediatr.2102feb,49(2);145-6
- Nonmanipulative relief for chronic back pain Rapid Response BMJ
- Study of orofacial response to manually dexterous task in mentally disabled children Paper presentation IAPSM
- Abdominoelectrography Proceedings Intelligent system and communications 2005, Manipal
- Lymphnode ratio as an alternative to pN staging in node positive breast cancer Poster Presentation ISMPO 2015
- Low axillary sampling in women with clinically node-negative breast cancer post neoadjuvant chemotherapy: a retrospective study Poster Presentation Advances in breast Cancer 2016, Mumbai
- Low axillary sampling in women with clinically node negative breast cancer post neoadjuvant chemotherapy: a retrospective study Oral presentation Advances in breast Cancer 2016, Mumbai
- Phyllodes : A Retrospective Audit Oral Presentation 2nd Indian cancer congress , Bangalore
- Management of breast cancer Chapter Text book of clinical oncology in the Indian context
- Inflammatory Breast Cancer Chapter Roshan Lall Gupta’s Recent Advances in Surgery 17th edition 2021
- Clinical Benefit of Circulating Tumor DNA Analysis in Early-Stage Breast Cancer Letter to the editor JAMA Oncology. 10.1001/jamaoncol.2019.5677
- Tale of constant adaptation, revision, and change of cancer therapy during the ongoing COVID crisis: Adapting to cope and win Article Indian Journal of Medical and Pediatric Oncology(Vol. 41, Issue 2)
- Validation of nomograms to predict nonsentinel lymph node metastasis after positive sentinel lymph node in breast cancer: Indian cohort background. Conference abstract ASCO Journal of Clinical Oncology 2020 38:15_suppl, 56 8-568
- En Bloc Excision of Phyllodes Tumor of the Breast: Radical Approach Heralds Better Outcome Original research Article Clinical Breast Cancer,2020 https://doi.org/10.1016/j.clbc.2 020.09.002
- Can We Avoid Axillary Lymph Node Dissection (ALND) in Patients with 1–2 Positive Sentinel/Low Axillary Lymph Nodes (SLN/LAS+) in the Indian Setting? Article Indian J Surg Oncol (2021)
- Knowledge attitude and practice of surgeons for breast conserving surgery: Results from an Indian cohort Article European Journal of Cancer, 10.1016/S0959-8049(20)30611- 0
- Access to HER2-targeted therapy at a tertiary care center in India: An evolution Article Indian J Cancer. 2021 Mar 21. doi: 10.4103/ijc.IJC_841_19. Epub ahead of print. PMID: 33753630.
- Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study Article BMJ Open 2021;11:e042943. doi: 10. 1136/bmjopen-2020-042943
- Reproductive factors and gall-bladder cancer, and the effect of common genetic variants on these associations: a case-control study in India.
- Phyllodes Tumour: A single institution retrospective audit of 433 cases
- Abstract P4-05-14: Validation of PREDICT version 2.2 on a retrospective cohort of Indian women with operable breast cancer
- 90PIntraoperative frozen section analysis of lymph nodes in women undergoing axillary sampling for treatment of Ca breast
- PO-1090 Tumor bed boost volume delineation and planning post-oncoplasty following multidisciplinary approach
- Abstract OT1-08-01: Concurrent versus sequential chemo-endocrine therapy in er positive and her2 negative non-metastatic breast cancer- an open-label, phase III, randomized controlled trial
- Molecular Biology in the Breast Clinics— Current status and future perspectives
